These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 36613838)

  • 21. Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells.
    Lindoso RS; Collino F; Vieyra A
    Stem Cell Investig; 2017; 4():75. PubMed ID: 29057247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance.
    Dörsam B; Reiners KS; von Strandmann EP
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells.
    Lindoso RS; Collino F; Camussi G
    Oncotarget; 2015 Apr; 6(10):7959-69. PubMed ID: 25797265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The extracellular matrix niche microenvironment of neural and cancer stem cells in the brain.
    Reinhard J; Brösicke N; Theocharidis U; Faissner A
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):174-183. PubMed ID: 27157088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
    Singh D; Khan MA; Siddique HR
    Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Stem Cells: Devil or Savior-Looking behind the Scenes of Immunotherapy Failure.
    Castagnoli L; De Santis F; Volpari T; Vernieri C; Tagliabue E; Di Nicola M; Pupa SM
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy.
    Chen J; Fei X; Wang J; Cai Z
    Pharmacol Res; 2020 Sep; 159():105041. PubMed ID: 32580030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.
    Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X
    Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
    Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
    Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer and Cancer Stem Cells: New Molecular Perspectives.
    Gurel C; Inetas G; Hortu I; Tunc E; Kuscu GC; Dindaroglu FC; Sahin O; Buhur A; Oktem G
    Crit Rev Oncog; 2019; 24(1):99-104. PubMed ID: 31679224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment.
    Ma F; Vayalil J; Lee G; Wang Y; Peng G
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy.
    Zhou Q; Yan Y; Li Y; Fu H; Lu D; Li Z; Wang Y; Wang J; Zhu H; Ren J; Luo H; Tao M; Cao Y; Wei S; Fan S
    Biomed Pharmacother; 2022 Dec; 156():113790. PubMed ID: 36244269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
    Nassar D; Blanpain C
    Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem cell-immune cell crosstalk in tumour progression.
    Bayik D; Lathia JD
    Nat Rev Cancer; 2021 Aug; 21(8):526-536. PubMed ID: 34103704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunology of cancer stem cells in solid tumours. A review.
    Maccalli C; Volontè A; Cimminiello C; Parmiani G
    Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.